Home › Companies › OUTSET MEDICAL INC. › 2024-2025
At OUTSET MEDICAL INC.'s 2 shareholder meetings in the 2024-2025 proxy season (held March 5, 2025 and June 2, 2025), 72 asset managers reported how they voted on 10 ballot items in their SEC Form N-PX filings, covering 366 separate fund positions. On the most widely held item of the season, voted at the meeting held June 2, 2025 — To approve, on a non-binding basis, the 2024 compensation of our named executive officers — OUTSET MEDICAL INC.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: OUTSET MEDICAL INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and OUTSET MEDICAL INC.’s Form 8-K, filed June 3, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 2, 2025: 6 items on OUTSET MEDICAL INC.’s Form 8-K, filed June 3, 2025: 4 approved · 2 without a stated outcome.
Meeting of March 5, 2025: 4 items on OUTSET MEDICAL INC.’s Form 8-K, filed March 6, 2025: 4 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore OUTSET MEDICAL INC. in the interactive database Compare manager voting policies
These tallies are OUTSET MEDICAL INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX. OUTSET MEDICAL INC. reported 2 meetings in this season; each is tabulated separately below, with its own filing.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: D. Keith Grossman | 13,775,602 | -- | -- | 146,871 | 1,412,525 | 99% | Not verified | — |
| Elect Director: Patrick T. Hackett | 13,827,416 | -- | -- | 95,057 | 1,412,525 | 99.3% | Not verified | — |
| 2. Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2024 compensation of the Company's named executive officers as disclosed in its 2024 proxy statement on a non-binding advisory basis | 13,574,133 | 342,501 | 5,839 | -- | 1,412,525 | 98% | Approved | — |
| 3. Amendment to 2020 Equity Incentive Plan The proposal to approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares | 10,989,378 | 2,932,488 | 607 | -- | 1,412,525 | 79% | Approved | — |
| 4. Amendment to Employee Stock Purchase Plan The proposal to approve an amendment to the Company's Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 255,000 shares | 13,661,326 | 259,632 | 1,515 | -- | 1,412,525 | 98% | Approved | — |
| 5. Ratification of Appointment of Independent Registered Public Accounting Firm | 15,318,214 | 12,527 | 4,257 | -- | -- | 99.9% | Approved | — |
Source: OUTSET MEDICAL INC., Form 8-K, filed with the SEC on June 3, 2025 — read the filing on EDGAR.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of, or in excess of, 20% of the Company's outstanding common stock upon the conversion of the Company's Series A Non-Voting Convertible Preferre | 14,821,054 | 1,505,272 | 153,928 | -- | 16,774,103 | 91% | Approved | — |
| 2. D&O Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(c), the issuance of the Company's Series A Non-Voting Convertible Preferred Stock to certain of the Company's directors, officers and employees and any sh | 14,654,560 | 1,597,360 | 228,334 | -- | 16,774,103 | 90% | Approved | — |
| 3. Reverse Stock Split Proposal The proposal to approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-10 and | 28,379,878 | 4,685,149 | 189,330 | -- | -- | 86% | Approved | — |
| 4. Adjournment Proposal The proposal to approve the adjournment of the Special Meeting, if necessary in the reasonable discretion of the Board, Chair of the Board, the President or the Corporate Secretary to solicit additional proxies if there are insufficient | 29,210,133 | 3,077,216 | 967,008 | -- | -- | 90% | Approved | — |
Source: OUTSET MEDICAL INC., Form 8-K, filed with the SEC on March 6, 2025 — read the filing on EDGAR.
Each item below shows how the 72 asset managers that disclosed a OUTSET MEDICAL INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Meeting held June 2, 2025.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: D. Keith Grossman
OUTSET MEDICAL INC.’s own tally for this item (“Elect Director: D. Keith Grossman”): 13,775,602 for, 146,871 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 4,395,426 for, 3,109 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,525,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 25,877 | 0 | 0 | 0 | For |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 4,123 | 0 | 0 | 374 | Mixed |
| BlackRock | 0 | 0 | 0 | 2,271 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 366 | Withhold |
| Invesco | 0 | 0 | 0 | 48 | Withhold |
| Guggenheim | 0 | 0 | 0 | 36 | Withhold |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 0 | 0 | 14 | Withhold |
Meeting held June 2, 2025.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Patrick T. Hackett
OUTSET MEDICAL INC.’s own tally for this item (“Elect Director: Patrick T. Hackett”): 13,827,416 for, 95,057 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 4,398,133 for, 402 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,525,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 25,877 | 0 | 0 | 0 | For |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 4,497 | 0 | 0 | 0 | For |
| BlackRock | 2,271 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 366 | Withhold |
| Invesco | 48 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 36 | Withhold |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 14 | 0 | 0 | 0 | For |
Meeting held March 5, 2025.
Combines 2 wordings of this item as funds reported it.
86% Approved · of votes cast
Description as filed by funds: Approval of an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-15, inclusive, as determined by the Company's board of directors in its discretion, subject to the Company's board of directors' authority to abandon such amendments; and
OUTSET MEDICAL INC.’s own tally for this item (“3. Reverse Stock Split Proposal The proposal to approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging fro”): 28,379,878 for, 4,685,149 against — passed, per its Form 8-K filed March 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three: Reverse Stock Split Proposal The proposal to approve an amendment to the Company's amended and restated certificate of incorporation to effect a reverse stock split of the Company's common stock at a ratio ranging from any whole number between 1-for-10 and 1-for-15, inclusive, as de…”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 4,351,853 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,589,292 | 0 | 0 | 0 | For |
| Fidelity | 1,358,230 | 0 | 0 | 0 | For |
| Morgan Stanley | 272,820 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 100,000 | 0 | 0 | 0 | For |
| Equitable | 19,520 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| Invesco | 2,809 | 0 | 0 | 0 | For |
| BlackRock | 1,243 | 0 | 0 | 0 | For |
| Guggenheim | 548 | 0 | 0 | 0 | For |
| MassMutual | 400 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 191 | 0 | 0 | 0 | For |
Meeting held March 5, 2025.
Combines 2 wordings of this item as funds reported it.
90% Approved · of votes cast
Description as filed by funds: Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of the Company's Series A Preferred Stock to certain of the Company's directors, officers and employees and any shares of the Company's common stock issuable upon the conversion thereof;
OUTSET MEDICAL INC.’s own tally for this item (“2. D&O Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(c), the issuance of the Company's Series A Non-Voting Convertible Preferred Stock to certain of the Company's dire”): 14,654,560 for, 1,597,360 against — passed, per its Form 8-K filed March 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two: D&O Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(c), the issuance of the Company's Series A Non-Voting Convertible Preferred Stock to certain of the Company's directors, officers and employees and any shares of the Company's common…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 4,351,853 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,589,292 | 0 | 0 | 0 | For |
| Fidelity | 1,358,230 | 0 | 0 | 0 | For |
| Morgan Stanley | 272,820 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 100,000 | 0 | 0 | 0 | For |
| Equitable | 19,520 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| Invesco | 2,809 | 0 | 0 | 0 | For |
| BlackRock | 1,243 | 0 | 0 | 0 | For |
| Guggenheim | 548 | 0 | 0 | 0 | For |
| MassMutual | 400 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 191 | 0 | 0 | 0 | For |
Meeting held March 5, 2025.
Combines 3 wordings of this item as funds reported it.
91% Approved · of votes cast
Description as filed by funds: Approval, for purposes of complying with Nasdaq Listing Rule 5635, of the issuance of, or in excess of, 20% of the Company's outstanding common stock upon conversion of the Series A Preferred Stock at less than the "minimum price and which may be deemed a "change of control" under Nasdaq Listing Rule 5635;
OUTSET MEDICAL INC.’s own tally for this item (“1. Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of, or in excess of, 20% of the Company's outstanding common stock upon the conversion of the Company's ”): 14,821,054 for, 1,505,272 against — passed, per its Form 8-K filed March 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 1: Issuance Proposal The proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635, the issuance of, or in excess of, 20% of the Company's outstanding common stock upon the conversion of the Company's Series A Non-Voting Convertible Preferred Stock at ”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 4,351,853 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,589,292 | 0 | 0 | 0 | For |
| Fidelity | 1,358,230 | 0 | 0 | 0 | For |
| Morgan Stanley | 272,820 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 100,000 | 0 | 0 | 0 | For |
| Equitable | 19,520 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| Invesco | 2,809 | 0 | 0 | 0 | For |
| BlackRock | 1,243 | 0 | 0 | 0 | For |
| Guggenheim | 548 | 0 | 0 | 0 | For |
| MassMutual | 400 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 191 | 0 | 0 | 0 | For |
Meeting held March 5, 2025.
90% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY IN THE REASONABLE DISCRETION OF THE COMPANY'S BOARD OF DIRECTORS, THE CHAIR OF THE BOARD, THE PRESIDENT OR THE CORPORATE SECRETARY TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE SPECIAL MEETING TO APPROVE ANY OF THE OTHER PROPOSALS.
OUTSET MEDICAL INC.’s own tally for this item (“4. Adjournment Proposal The proposal to approve the adjournment of the Special Meeting, if necessary in the reasonable discretion of the Board, Chair of the Board, the President or the Corporate Secretary to solicit addi”): 29,210,133 for, 3,077,216 against — passed, per its Form 8-K filed March 6, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Four: Adjournment Proposal The proposal to approve the adjournment of the Special Meeting, if necessary in the reasonable discretion of the Board, Chair of the Board, the President or the Corporate Secretary to solicit additional proxies if there are insufficient votes at the time of the S…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 11 asset managers below reported 4,351,453 for, 400 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,589,292 | 0 | 0 | 0 | For |
| Fidelity | 1,358,230 | 0 | 0 | 0 | For |
| Morgan Stanley | 272,820 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 100,000 | 0 | 0 | 0 | For |
| Equitable | 19,520 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 6,800 | 0 | 0 | 0 | For |
| Invesco | 2,809 | 0 | 0 | 0 | For |
| BlackRock | 1,243 | 0 | 0 | 0 | For |
| Guggenheim | 548 | 0 | 0 | 0 | For |
| MassMutual | 0 | 400 | 0 | 0 | Against |
| Advisors' Inner Circle Fund III | 191 | 0 | 0 | 0 | For |
Meeting held June 2, 2025.
79% Approved · of votes cast
Description as filed by funds: To approve an amendment to our 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares
OUTSET MEDICAL INC.’s own tally for this item (“3. Amendment to 2020 Equity Incentive Plan The proposal to approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,”): 10,989,378 for, 2,932,488 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Three: Amendment to 2020 Equity Incentive Plan The proposal to approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock available for issuance under the plan by 1,950,000 shares was approved by the following vote:”
Support: 79% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 1,839,655 for, 2,558,913 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 0 | 2,525,771 | 0 | 0 | Against |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 0 | 25,877 | 0 | 0 | Against |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 0 | 4,497 | 0 | 0 | Against |
| BlackRock | 0 | 2,271 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 366 | 0 | 0 | Against |
| Invesco | 0 | 48 | 0 | 0 | Against |
| Guggenheim | 0 | 36 | 0 | 0 | Against |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 33 | 0 | 0 | Against |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 14 | 0 | 0 | Against |
Meeting held June 2, 2025.
98% Approved · of votes cast
Description as filed by funds: To approve an amendment to our Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 255,000 shares
OUTSET MEDICAL INC.’s own tally for this item (“4. Amendment to Employee Stock Purchase Plan The proposal to approve an amendment to the Company's Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 25”): 13,661,326 for, 259,632 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Four: Amendment to Employee Stock Purchase Plan The proposal to approve an amendment to the Company's Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance under the plan by 255,000 shares was approved by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 13 asset managers below reported 4,395,890 for, 2,678 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,525,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 25,877 | 0 | 0 | 0 | For |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 4,123 | 374 | 0 | 0 | Mixed |
| BlackRock | 0 | 2,271 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 366 | 0 | 0 | 0 | For |
| Invesco | 48 | 0 | 0 | 0 | For |
| Guggenheim | 36 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 0 | 33 | 0 | 0 | Against |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 14 | 0 | 0 | 0 | For |
Meeting held June 2, 2025.
Combines 8 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding basis, the 2024 compensation of our named executive officers
OUTSET MEDICAL INC.’s own tally for this item (“2. Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2024 compensation of the Company's named executive officers as disclosed in its 2024 proxy statement on a non-binding advisory basis”): 13,574,133 for, 342,501 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Two: Advisory Vote on Named Executive Officer Compensation The proposal to approve the 2024 compensation of the Company's named executive officers as disclosed in its 2024 proxy statement on a non-binding advisory basis was approved by the following vote: Since the Board is divided into th…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,525,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 25,877 | 0 | 0 | 0 | For |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 0 | 4,497 | 0 | 0 | Against |
| BlackRock | 0 | 2,271 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 366 | 0 | 0 | Against |
| Invesco | 0 | 48 | 0 | 0 | Against |
| Guggenheim | 0 | 36 | 0 | 0 | Against |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 14 | 0 | 0 | Against |
Fund voting reports, all 12 managers: 4,391,303 for, 7,232 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,531,293 | 0 | 0 | 0 | For |
| Durable Capital Partners LP | 1,740,216 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,520,843 | 2,620 | 0 | 0 | For |
| Woodline Partners LP | 1,319,711 | 0 | 0 | 0 | For |
| PERCEPTIVE ADVISORS LLC | 833,333 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 738,231 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 627,857 | 0 | 0 | 0 | For |
| Catalio Capital Management, LP | 166,666 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 0 | 87,488 | 0 | 0 | Against |
| Ensign Peak Advisors, Inc | 84,159 | 0 | 0 | 0 | For |
| C WorldWide Asset Management Fondsmaeglerselskab A/S | 0 | 66,666 | 0 | 0 | Against |
| BlackRock | 5,889 | 33,886 | 0 | 0 | Mixed |
| Birchview Capital, LP | 24,584 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 24,086 | 0 | 0 | Against |
| Morgan Stanley | 0 | 18,407 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 13,888 | 0 | 0 | 0 | For |
| PFM Health Sciences, LP | 11,719 | 0 | 0 | 0 | For |
| Northern Trust | 5,938 | 0 | 0 | 0 | For |
| Alyeska Investment Group, L.P. | 4,750 | 0 | 0 | 0 | For |
| Vanguard | 1,199 | 1,909 | 0 | 0 | Mixed |
| Fiera Capital Corp | 0 | 2,931 | 0 | 0 | Against |
| Renaissance | 0 | 2,915 | 0 | 0 | Against |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 0 | 2,810 | 0 | 0 | Against |
| HighTower Advisors, LLC | 0 | 2,169 | 0 | 0 | Against |
| State Street | 1,456 | 203 | 0 | 0 | Mixed |
Institutional-manager reports, all 65 managers: 9,632,670 for, 250,291 against. Showing the 25 largest; every one is in the interactive database (link above).
Meeting held June 2, 2025.
99.9% Approved · of votes cast
Description as filed by funds: To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2025
OUTSET MEDICAL INC.’s own tally for this item (“5. Ratification of Appointment of Independent Registered Public Accounting Firm”): 15,318,214 for, 12,527 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal Five: Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025 by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 4,398,535 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 2,525,771 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,101,400 | 0 | 0 | 0 | For |
| MFS | 731,671 | 0 | 0 | 0 | For |
| Vanguard | 25,877 | 0 | 0 | 0 | For |
| Pacific Life | 6,560 | 0 | 0 | 0 | For |
| Equitable | 4,497 | 0 | 0 | 0 | For |
| BlackRock | 2,271 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 366 | 0 | 0 | 0 | For |
| Invesco | 48 | 0 | 0 | 0 | For |
| Guggenheim | 36 | 0 | 0 | 0 | For |
| MassMutual | 24 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 14 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 17,722,310 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.25% |
| 2 | T. Rowe Price | 6.21% |
| 3 | MFS | 4.13% |
| 4 | Vanguard | 0.15% |
| 5 | Pacific Life | 0.04% |
| 6 | Equitable | 0.03% |
| 7 | BlackRock | 0.01% |
| 8 | Blackstone Alternative Investment Funds | <0.01% |
| 9 | Invesco | <0.01% |
| 10 | Guggenheim | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 14.28% |
| 2 | Durable Capital Partners LP | 9.82% |
| 3 | T. Rowe Price | 8.60% |
| 4 | Woodline Partners LP | 7.45% |
| 5 | PERCEPTIVE ADVISORS LLC | 4.70% |
| 6 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 4.17% |
| 7 | MARSHALL WACE, LLP | 3.54% |
| 8 | Catalio Capital Management, LP | 0.94% |
| 9 | GMT CAPITAL CORP | 0.49% |
| 10 | Ensign Peak Advisors, Inc | 0.47% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 14.65% | 13G |
| FMR (Fidelity) | 14.65% | 13F |
| BML Investment Partners, L.P. | 14.22% | 13G |
| Perceptive Advisors LLC | 6.82% | 13G |
| BANK OF AMERICA CORP /DE/ | 5.36% | 13G |
| PFM Health Sciences, LP | 3.00% | 13G |
| Woodline Partners LP | 1.65% | 13G |
| Vanguard Group | 0.98% | 13F |
| Millennium Management | 0.65% | 13F |
| BlackRock | 0.37% | 13F |
Percentages above are of 17,722,310 shares outstanding, as reported by OUTSET MEDICAL INC. on its Form 10-Q dated May 2, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from OUTSET MEDICAL INC.’s 10-Q dated May 2, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
OUTSET MEDICAL INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “OUTSET MEDICAL (OM) 2025 Annual & Special Meetings: Vote Results”, https://proxyvotesnow.com/company/outset-medical-inc/2025 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.